These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26359326)

  • 21. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone union rate with recombinant human bone morphogenic protein-2 versus autologous iliac bone in PEEK cages for anterior lumbar interbody fusion.
    Flouzat-Lachaniette CH; Ghazanfari A; Bouthors C; Poignard A; Hernigou P; Allain J
    Int Orthop; 2014 Sep; 38(9):2001-7. PubMed ID: 24627122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biological substitutes/extenders for spinal arthrodesis: which agents are cost-effective?
    Hsu WK; Hashimoto RE; Berven SH; Nassr A
    Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S86-98. PubMed ID: 25299264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft.
    Maeda T; Buchowski JM; Kim YJ; Mishiro T; Bridwell KH
    Spine (Phila Pa 1976); 2009 Sep; 34(20):2205-12. PubMed ID: 19752707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the use of rhBMP-7 versus iliac crest autograft in single-level lumbar fusion: a meta-analysis of randomized controlled trials.
    Ye F; Zeng Z; Wang J; Liu H; Wang H; Zheng Z
    J Bone Miner Metab; 2018 Jan; 36(1):119-127. PubMed ID: 28342094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 3: assessment of economic outcome.
    Ghogawala Z; Whitmore RG; Watters WC; Sharan A; Mummaneni PV; Dailey AT; Choudhri TF; Eck JC; Groff MW; Wang JC; Resnick DK; Dhall SS; Kaiser MG
    J Neurosurg Spine; 2014 Jul; 21(1):14-22. PubMed ID: 24980580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD; Kim JY
    J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo Assessment of AMP2, a Novel Ceramic-Binding BMP-2, in Ovine Lumbar Interbody Fusion.
    Christou C; Varcoe T; Williams G; Heil T; Leifeld S; Park H; Peckham S; Stewart D; Greenbaum J; Wang T; Pelletier M; Walsh W; Alvarez L
    Spine (Phila Pa 1976); 2024 Oct; 49(19):1381-1390. PubMed ID: 38988089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Counting the Cost of Failed Spinal Fusion for Relief of Low Back Pain: Does Primary Fusion With Bone Morphogenetic Protein Make Economic Sense From a Primary Payer Perspective?
    Lloyd AP
    Clin Spine Surg; 2017 Jul; 30(6):E720-E724. PubMed ID: 28632559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion.
    Kaiser MG; Groff MW; Watters WC; Ghogawala Z; Mummaneni PV; Dailey AT; Choudhri TF; Eck JC; Sharan A; Wang JC; Dhall SS; Resnick DK
    J Neurosurg Spine; 2014 Jul; 21(1):106-32. PubMed ID: 24980593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posterolateral lumbar spine fusion with INFUSE bone graft.
    Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grafton and local bone have comparable outcomes to iliac crest bone in instrumented single-level lumbar fusions.
    Kang J; An H; Hilibrand A; Yoon ST; Kavanagh E; Boden S
    Spine (Phila Pa 1976); 2012 May; 37(12):1083-91. PubMed ID: 22076647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Effectiveness Analysis of Demineralized Bone Matrix and rhBMP-2 versus Autologous Iliac Crest Bone Grafting in Alveolar Cleft Patients.
    Mehta S; Blagg R; Willcockson J; Gociman B; Yamashiro D; Siddiqi F
    Plast Reconstr Surg; 2018 Sep; 142(3):737-743. PubMed ID: 30148776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RhBMP-2 is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity: 4- to 14-year follow-up.
    Kim HJ; Buchowski JM; Zebala LP; Dickson DD; Koester L; Bridwell KH
    Spine (Phila Pa 1976); 2013 Jun; 38(14):1209-15. PubMed ID: 23392417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
    J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of recombinant human bone morphogenetic protein-2 in an experimental model of spinal fusion in a radiated area.
    Ames CP; Smith JS; Preul MC; Crawford NR; Kim GE; Nottmeier E; Chamberlain R; Speiser B; Sonntag VK; Dickman CA
    Spine (Phila Pa 1976); 2005 Dec; 30(23):2585-92. PubMed ID: 16319743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes and fusion rates following anterior lumbar interbody fusion with bone graft substitute i-FACTOR, an anorganic bone matrix/P-15 composite.
    Mobbs RJ; Maharaj M; Rao PJ
    J Neurosurg Spine; 2014 Dec; 21(6):867-76. PubMed ID: 25325176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate.
    Baskin DS; Ryan P; Sonntag V; Westmark R; Widmayer MA
    Spine (Phila Pa 1976); 2003 Jun; 28(12):1219-24; discussion 1225. PubMed ID: 12811263
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of autologous iliac crest bone graft and bone morphogenetic proteins for posterolateral fusion of lumbar spine: a meta-analysis of the results.
    Papakostidis C; Kontakis G; Bhandari M; Giannoudis PV
    Spine (Phila Pa 1976); 2008 Sep; 33(19):E680-92. PubMed ID: 18758349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.